BeStock  
Stocks › Medical Devices › BSX

Boston Scientific BSX

US equityMarket cap rank #358Medical DevicesBrain-Computer Interface
$42.75 −$1.89 (-4.23%)
Market closed · Nov 6, 9:50 pm ET · Last extended-hours $42.80 +0.12%
Open$43.35
Prev close$44.64
Day range$42.69 – $43.63
Volume14.71M
Market cap$61.96B
P/E (TTM)18.0
Dividend yield–

Earnings

Average move on report day±3.7%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+9.0%
Worst reaction-17.6%

Stock move on the day after each report

-0.4%2023/Q3+5.7%2024/Q1-1.1%2024/Q2-0.6%2024/Q3+1.4%2024/Q4+4.1%2025/Q1+4.5%2025/Q2+4.0%2025/Q3-17.6%2025/Q4+9.0%2026/Q10.0%2026/Q2-5.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q328 Oct 2026Pre Market±7.6%-5.84%Within range
2026/Q229 Jul 2026Pre Market±7.8%-0.04%Within range
2026/Q122 Apr 2026Pre Market±6.0%+8.99%Bigger than priced
2025/Q44 Feb 2026Pre Market±4.7%-17.59%Bigger than priced
2025/Q322 Oct 2025Pre Market±3.9%+3.95%Bigger than priced
2025/Q223 Jul 2025Pre Market±5.0%+4.46%Within range
2025/Q123 Apr 2025None±6.2%+4.07%Within range
2024/Q45 Feb 2025None±4.5%+1.38%Within range
2024/Q323 Oct 2024Pre Market±6.4%-0.64%Within range
2024/Q224 Jul 2024Pre Market–-1.06%–
2024/Q124 Apr 2024Pre Market±5.8%+5.68%Within range
2023/Q326 Oct 2023Pre Market±4.1%-0.42%Within range
2023/Q227 Jul 2023None±5.0%+0.46%Within range
2023/Q126 Apr 2023None±6.9%-0.02%Within range
2022/Q41 Feb 2023None±5.5%+2.79%Within range
2022/Q326 Oct 2022None±4.9%+1.19%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Cardiovascular$3.62B 66.6%
  • MedSurg$1.82B 33.4%
  • Impact of foreign currency fluctuations$2.00M 0.0%

Fundamentals

Full statements →

Latest reported quarter: Q3, ended Sep 2026

Revenue$5.14B+1.4% YoY
Operating profit$979.00M-6.8% YoY
Net profit$580.00M-23.2% YoY
Diluted EPS$0.40-21.6% YoY
Free cash flow-$451.00M-143.3% YoY
Operating cash flow$1.47B

Revenue, last 8 quarters

$4.6BDec '24$4.7BMar '25$5.1BJun '25$5.1BSep '25$5.3BDec '25$5.2BMar '26$5.4BJun '26$5.1BSep '26

Net profit, last 8 quarters

$562.0MDec '24$672.0MMar '25$795.0MJun '25$755.0MSep '25$670.0MDec '25$1.3BMar '26$905.0MJun '26$580.0MSep '26

Profitability & balance sheet

Gross margin69.1%
Operating margin20.6%
Net margin16.6%
Liabilities / assets44.3%
Cash & investments$539.00M
Total debt$12.62B
Net cash (debt)-$12.09B

Discussion

No comments yet — be the first to weigh in on BSX.

Sign in to join the discussion.

Scroll to Top